Objectives: We evaluated the relationship between serum gamma-glutamyltransferase (GGT) levels and the burden of atherosclerosis in patients with acute coronary syndrome (ACS).
C oronary artery disease (CAD) is the most common cause of mortality around the world. [1] [2] [3] Several risk factors have been defined as predictors of coronary atherosclerosis. [2] [3] [4] [5] Previous reports demonstrated that serum gamma-glutamyltransferase (GGT) is an independent risk factor for the development of CAD and the morbidity and mortality associated with cardiovascular disease. [6] [7] [8] GGT activity has been observed in coronary atherosclerotic plaques. [9] In addition, serum GGT is an independent risk factor for diabetes mellitus, stroke and hypertension. [10, 11] The burden of atherosclerosis is strongly associated with cardiovascular prognosis in patients with acute coronary syndrome (ACS). [12] Therefore, prediction and diagnosis of the burden of atherosclerosis is critical in clinical practice. The aim of the current study was to evaluate the relationship between serum GGT and the burden of atherosclerosis in patients with ACS.
PATIENTS AND METHODS

Patients
The study involved 180 patients admitted to the hospital with ACS and who underwent coronary angiography. Patients with a history of prior myocardial infarction (MI), history of/detected renal disease, cerebrovascular event, peripheral arterial disease, percutaneous coronary intervention, or coronary bypass surgery were excluded. Other exclusion criteria were alcohol consumption and possible liver dysfunction defined as aspartate-aminotransferase (AST) or alanine-aminotransferase (ALT) levels >50 U/L. Two study groups were established based on the diagnostic criteria of CAD: non-ST-segment elevation MI (non-STEMI) and unstable angina pectoris (USAP). Informed consent was obtained from all patients. The study was approved by our local ethical committee. All demographic and clinical data were collected prospectively.
Laboratory analysis
Fasting blood samples were drawn for the measurement of blood glucose, plasma total cholesterol, highdensity lipoprotein cholesterol, low-density lipoprotein cholesterol, and plasma triglycerides (Thermo Scientific Konelab PRIME 60 Clinical Chemistry Analyzer, Helsinki, Finland) in all cases. Serum GGT levels were measured at 37ºC by enzymatic calorimetric test using a Roche/Hitachi analyzer (Mannheim, Germany). [7] Coronary angiography Quantitative coronary angiography was performed by two experienced interventional cardiologists who had no knowledge of the study design or the patient group designations. Gensini and Syntax scores were used to evaluate the grading and complexity of CAD. [13, 14] For the Gensini score, the most severe stenosis in each of eight coronary segments (left anterior descending artery, main diagonal branch, first septal perforator, left circumflex artery, obtuse marginal and posterolateral vessels, right coronary artery, and main descending branch) was graded from 1 to 4 (1-49% lumen diameter reduction: 1 point, 50-74% stenosis: 2 points, 75-99% stenosis: 3 points, 100% occlusion: 4 points) for a total score between 0 and 32. Syntax score was calculated with Syntax score calculator 2.1 (www. syntaxscore.com). The Syntax score was classified as tertiles as follows: low Syntax score (≤22), intermediate Syntax score (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) , and high Syntax score (≥33). The number of diseased vessel with >50% luminal stenosis was scored from 1 to 3 or more diseased vessels. Coronary stenotic lesions with >50% luminal stenosis were defined as critical lesions and vessels with <50% luminal stenosis were defined as non-critical lesions.
Statistical analysis
All analyses were performed using SPSS for Windows 16.0 (version 16.0, SPSS, Chicago, Illinois, USA). Quantitative variables were expressed as mean value ± SD for parametric variables, and median and minimum-maximum levels for non-parametric variables. Continuous variables were analyzed for normal distribution using the Kolmogorov-Smirnov test and analyzed for homogeneity using the Levene tests. The Pearson test was used for correlation of parametric variables and the Spearman test was used for non-parametric variables. Multivariate linear regression analysis was performed to evaluate the effects of the variables on the Gensini score and Syntax score. A two-tailed p<0.05 was considered significant.
RESULTS
Relationships between Syntax score and clinical and laboratory findings are shown in Table 1 . Compared to the low Syntax group, age and glucose levels were higher and hemoglobin levels were lower in intermediate Syntax group. In addition, there were more diabetic and hypertensive patients and fewer smoking patients in the intermediate Syntax score group. Compared to the low Syntax score group, levels of GGT and creatinine were higher in high Syntax score group. Finally, the number of diabetic and hypertensive patients was greater in the high Syntax score group (Table 1) .
Baseline clinical characteristics of the study population according to the angiographic findings are shown in Table 2 . One, two, and three or more diseased vessels were detected in 46 (25.6%), 52 (28.9%), and 82 (45.6%) patients, respectively. Age and serum GGT, serum glucose, and blood urea nitrogen (BUN) levels were increased in patients with two and three or more diseased vessels compared to patients with one diseased vessel ( Table 2) . Additionally, the number of patients with diabetes, hyperten- strated that increased GGT level was an independent risk factor for Gensini and Syntax scores (β=0.244, p=0.029 and β=0.227, p=0.035, respectively), together with age (p=0.001 and, p=0.002, respectively) and glucose (p=0.017 and p=0.012, respectively) ( Table 3 ).
DISCUSSION
We examined the level of serum GGT in patients with ACS to estimate the burden of atherosclerosis. Our findings indicate that high levels of GGT were associated with burden of atherosclerosis in patients with ACS.
To date, no studies were found that focus on an association between serum GGT activity and burden of atherosclerosis in patients with ACS. The results of studies in patients with CAD who underwent angiogsion, and smoking history was among the patients with multivessel disease. Correlation analysis revealed that the level of GGT was associated with Gensini and Syntax scores (r=0.378, p<0.001 and r=0.301, p<0.001, respectively) (Figure 1) , number of diseased vessel (r=0.355 p<0.001) (Figure 2 ), and number of critical lesions (for >70%, r=0.159 and p=0.036). Gensini score was associated with serum levels of GGT (r=0.378, p<0.001), BUN (r=0.167, p=0.028), creatinine (r=0.266, p<0.001), glucose (r=0.234, p=0.002) and age (r=0.208, p=0.006). Syntax score was significantly correlated with GGT (r=0.301, p<0.001), age (r=0.231, p=0.002), creatinine (r=0.195, p=0.009), diastolic blood pressure (r=0.263, p=0.013), BUN (r=0.213, p=0.004), and glucose (r=0.307, p<0.001).
Multivariate linear regression analysis demon- raphy were controversial. Recently, Aksakal et al. [15] have reported that baseline serum GGT activity was independently associated with the complexity of the coronary lesions and all-cause mortality rate throughout long-term follow-up in patients with stable angina pectoris. Açikel et al. [16] found a significant relationship between serum GGT levels and CAD extent and severity assessed by Gensini scoring in patients who underwent coronary angiography, whereas Demircan et al. [17] observed no correlation between the number of affected vessels and GGT levels.
Elevated serum GGT concentration is an independent cardiac risk factor and predicts cardiovascular events, non-fatal MI, and cardiac mortality in unselected populations, in patients with history of MI, and in patients with ACS after adjusting for other known CAD risk factors as well as alcohol consumption. [6] [7] [8] 18, 19] In patients with stable CAD, serum GGT was associated with prognosis independent of a variety of established risk markers. [20] The underlying mechanisms linking GGT and cardiovascular mortality have not yet been clearly demonstrated. We suggested that high GGT levels were associated with burden of atherosclerosis and this may explain the cardiovascular outcomes associated with increased GGT levels.
Serum GGT is a marker of alcohol intake but may also reflect oxidative stress and nonalcoholic fatty liver disease. [21] [22] [23] Serum GGT catalyzes the first step in the degradation of extracellular antioxidant glutathione, allowing for precursor amino acids to be reutilized for intracellular glutathione synthesis. [23] It has been shown that the degradation of glutathione can play a pro-oxidant role in selected conditions, as well as production of reactive oxygen species. [24] Higher serum GGT was associated with both inflammation and oxidative stress, both of which are proposed as key mechanisms of atherosclerosis. [10] Specific pathogenetic mechanisms (from inflammation to lipid accumulation and oxidation within the plaque) likely contribute to the potential mechanism in atherosclerosis and plaque destabilization. [21] Serum GGT can trigger the oxidative stress within plaque and can contribute to the vulnerability and evolution of the plaques. [21] Serum gamma-glutamyltransferase and the burden of atherosclerosis in patients with ACS 279 ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ Although the physiopathogenesis of the association between elevated GGT and burden of atherosclerosis is not completely understood, multiple mechanisms may be involved. Firstly, as we know, inflammatory process plays a key role in atherosclerosis, and serum GGT activity can serve as a proinflammatory protein in atherosclerosis. [25, 26] Secondly, serum GGT can trigger progression and rupture of atherosclerotic plaques via LDL cholesterol oxidation. [21] Finally, serum GGT levels were positively associated with cardiac risk factors, which contribute to atherosclerotic processes, such as hypertension, diabetes, and metabolic syndrome. [27, 28] In our study, patients with high GGT had high Gensini and Syntax scores and had greater numbers of critical lesions. Therefore, elevated serum GGT may indicate that patients with ACS had severe CAD and had a higher risk of acute coronary events due to increased burden of atherosclerosis. High levels of GGT can be used for predicting of high-risk patients.
Gensini score
Previous reports showed that there is a close relationship between serum GGT levels and other prognostic factors, such as hypertension, metabolic syndrome, diabetes, dyslipidemia, and smoking. [27] [28] [29] But we do not have clear information about the association between GGT and known ischemic heart disease risk factors. In our study, high levels of serum GGT were associated with hypertension (p=0.001) and diabetes (p=0.016). Of note is that our study had sufficient numbers of diabetic and hypertensive patients to assess the impact of diabetes on burden of atherosclerosis.
Limitations
First, the assessment of coronary angiographic findings was limited to visual interpretation and angiography is a technique that detects only major coronary arterial lesions. Second, no information was available regarding the severity or duration of hypertension and other cardiovascular disease risk factors. We also have no data available for medication use. Third, the small sample size is the most important limitation of the present study. However, our population contains homogeneous unselected ACS patients submitted to coronary angiography, which mirrors a real world scenario. Fourth, this study was not a followup study. Fifth, we did not evaluate an association between serum GGT and well-known risk scores (eg. GRACE).
In conclusion, high levels of serum GGT on admission were associated with burden of atherosclerosis in patients with ACS. As serum GGT is a cost effective and simple vascular risk marker, its routine measurement on admission may be helpful in determining high-risk patients in clinical practice. 
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